

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | negative regulation of cell killing (GO:0031342) | 8.99251732 |
| 2 | negative regulation of leukocyte mediated cytotoxicity (GO:0001911) | 8.99251732 |
| 3 | regulation of isotype switching to IgG isotypes (GO:0048302) | 8.91724541 |
| 4 | negative T cell selection (GO:0043383) | 8.39154043 |
| 5 | negative thymic T cell selection (GO:0045060) | 8.19353288 |
| 6 | regulation of natural killer cell mediated immunity (GO:0002715) | 8.03042104 |
| 7 | regulation of natural killer cell mediated cytotoxicity (GO:0042269) | 8.03042104 |
| 8 | cellular response to interleukin-15 (GO:0071350) | 7.80759333 |
| 9 | positive regulation of gamma-delta T cell activation (GO:0046645) | 7.01837779 |
| 10 | positive thymic T cell selection (GO:0045059) | 6.95082232 |
| 11 | positive regulation of natural killer cell mediated cytotoxicity (GO:0045954) | 6.90885676 |
| 12 | positive regulation of natural killer cell mediated immunity (GO:0002717) | 6.90885676 |
| 13 | response to interleukin-15 (GO:0070672) | 6.81687429 |
| 14 | thymic T cell selection (GO:0045061) | 6.58235696 |
| 15 | activated T cell proliferation (GO:0050798) | 6.37747694 |
| 16 | positive T cell selection (GO:0043368) | 6.23789373 |
| 17 | T cell migration (GO:0072678) | 6.23610747 |
| 18 | regulation of B cell receptor signaling pathway (GO:0050855) | 5.97070080 |
| 19 | negative regulation by host of viral transcription (GO:0043922) | 5.86569517 |
| 20 | regulation of leukocyte mediated cytotoxicity (GO:0001910) | 5.84917739 |
| 21 | regulation of lymphocyte chemotaxis (GO:1901623) | 5.84336923 |
| 22 | positive regulation of isotype switching (GO:0045830) | 5.79696962 |
| 23 | positive regulation of defense response to virus by host (GO:0002230) | 5.76013039 |
| 24 | pyrimidine nucleoside catabolic process (GO:0046135) | 5.67785428 |
| 25 | leukocyte aggregation (GO:0070486) | 5.59537220 |
| 26 | regulation of gamma-delta T cell differentiation (GO:0045586) | 5.55968007 |
| 27 | T cell selection (GO:0045058) | 5.50908232 |
| 28 | regulation of cell killing (GO:0031341) | 5.36714409 |
| 29 | positive regulation of leukocyte mediated cytotoxicity (GO:0001912) | 5.29776114 |
| 30 | positive regulation of DNA recombination (GO:0045911) | 5.24515030 |
| 31 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 5.18547150 |
| 32 | positive regulation of immunoglobulin mediated immune response (GO:0002891) | 5.10561519 |
| 33 | positive regulation of B cell mediated immunity (GO:0002714) | 5.10561519 |
| 34 | natural killer cell activation (GO:0030101) | 5.03755485 |
| 35 | regulation of humoral immune response mediated by circulating immunoglobulin (GO:0002923) | 5.03232938 |
| 36 | T cell costimulation (GO:0031295) | 4.98997947 |
| 37 | regulation of response to tumor cell (GO:0002834) | 4.97951842 |
| 38 | positive regulation of response to tumor cell (GO:0002836) | 4.97951842 |
| 39 | positive regulation of immune response to tumor cell (GO:0002839) | 4.97951842 |
| 40 | regulation of immune response to tumor cell (GO:0002837) | 4.97951842 |
| 41 | positive regulation of cell killing (GO:0031343) | 4.97270137 |
| 42 | positive regulation of antigen receptor-mediated signaling pathway (GO:0050857) | 4.96826844 |
| 43 | cytolysis (GO:0019835) | 4.95404850 |
| 44 | regulation of gamma-delta T cell activation (GO:0046643) | 4.95009907 |
| 45 | lymphocyte costimulation (GO:0031294) | 4.93285558 |
| 46 | positive regulation of calcium-mediated signaling (GO:0050850) | 4.92818703 |
| 47 | eosinophil chemotaxis (GO:0048245) | 4.90617236 |
| 48 | positive regulation of T cell mediated cytotoxicity (GO:0001916) | 4.86175828 |
| 49 | T cell receptor signaling pathway (GO:0050852) | 4.85836228 |
| 50 | positive regulation of alpha-beta T cell proliferation (GO:0046641) | 4.74444459 |
| 51 | regulation of interleukin-12 biosynthetic process (GO:0045075) | 4.71157153 |
| 52 | regulation of isotype switching (GO:0045191) | 4.67556753 |
| 53 | negative regulation of viral genome replication (GO:0045071) | 4.55860321 |
| 54 | lymphocyte chemotaxis (GO:0048247) | 4.54045680 |
| 55 | regulation of immunoglobulin mediated immune response (GO:0002889) | 4.51066901 |
| 56 | * cellular defense response (GO:0006968) | 4.45664507 |
| 57 | regulation of regulatory T cell differentiation (GO:0045589) | 4.44061363 |
| 58 | positive regulation of lymphocyte migration (GO:2000403) | 4.43741942 |
| 59 | negative regulation of T cell mediated immunity (GO:0002710) | 4.41617244 |
| 60 | eosinophil migration (GO:0072677) | 4.40133941 |
| 61 | regulation of alpha-beta T cell proliferation (GO:0046640) | 4.39042319 |
| 62 | regulation of B cell mediated immunity (GO:0002712) | 4.34634341 |
| 63 | negative regulation of T cell apoptotic process (GO:0070233) | 4.24344676 |
| 64 | antigen receptor-mediated signaling pathway (GO:0050851) | 4.19907425 |
| 65 | sequestering of actin monomers (GO:0042989) | 4.13685339 |
| 66 | T cell differentiation involved in immune response (GO:0002292) | 4.13214564 |
| 67 | alpha-beta T cell differentiation involved in immune response (GO:0002293) | 4.13214564 |
| 68 | alpha-beta T cell activation involved in immune response (GO:0002287) | 4.13214564 |
| 69 | regulation of T cell tolerance induction (GO:0002664) | 4.11966436 |
| 70 | regulation of memory T cell differentiation (GO:0043380) | 4.09421761 |
| 71 | regulation of lymphocyte mediated immunity (GO:0002706) | 4.08510262 |
| 72 | negative regulation of viral transcription (GO:0032897) | 4.08473971 |
| 73 | cellular response to interferon-beta (GO:0035458) | 4.03996992 |
| 74 | response to interferon-beta (GO:0035456) | 4.01694975 |
| 75 | positive regulation of interleukin-2 biosynthetic process (GO:0045086) | 4.01484054 |
| 76 | lymphocyte migration (GO:0072676) | 3.99368997 |
| 77 | macrophage chemotaxis (GO:0048246) | 3.97569206 |
| 78 | regulation of interferon-gamma-mediated signaling pathway (GO:0060334) | 3.95179694 |
| 79 | positive regulation of type I interferon-mediated signaling pathway (GO:0060340) | 3.95164578 |
| 80 | positive regulation of lymphocyte mediated immunity (GO:0002708) | 3.94469336 |
| 81 | positive regulation of T cell cytokine production (GO:0002726) | 3.93281957 |
| 82 | regulation of response to interferon-gamma (GO:0060330) | 3.91124726 |
| 83 | leukocyte cell-cell adhesion (GO:0007159) | 3.89750421 |
| 84 | regulation of antigen receptor-mediated signaling pathway (GO:0050854) | 3.83429800 |
| 85 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 3.81842919 |
| 86 | antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 3.81842919 |
| 87 | negative regulation of lymphocyte mediated immunity (GO:0002707) | 3.79025270 |
| 88 | T cell differentiation (GO:0030217) | 3.71723819 |
| 89 | positive regulation of immunoglobulin production (GO:0002639) | 3.70640811 |
| 90 | regulation of T cell receptor signaling pathway (GO:0050856) | 3.67361650 |
| 91 | DNA demethylation (GO:0080111) | 3.65205440 |
| 92 | regulation of activation of Janus kinase activity (GO:0010533) | 3.63841350 |
| 93 | positive regulation of B cell differentiation (GO:0045579) | 3.60862862 |
| 94 | regulation of B cell differentiation (GO:0045577) | 3.58884005 |
| 95 | regulation of calcium-mediated signaling (GO:0050848) | 3.57916149 |
| 96 | alpha-beta T cell differentiation (GO:0046632) | 3.54229457 |
| 97 | cellular extravasation (GO:0045123) | 3.53626814 |
| 98 | negative regulation of antigen receptor-mediated signaling pathway (GO:0050858) | 3.53529223 |
| 99 | alpha-beta T cell activation (GO:0046631) | 3.52395762 |
| 100 | negative regulation of CD4-positive, alpha-beta T cell activation (GO:2000515) | 3.52299429 |
| 101 | modulation by host of symbiont transcription (GO:0052472) | 3.52008625 |
| 102 | modulation by host of viral transcription (GO:0043921) | 3.52008625 |
| 103 | T-helper cell differentiation (GO:0042093) | 3.51007385 |
| 104 | CD4-positive, alpha-beta T cell differentiation involved in immune response (GO:0002294) | 3.51007385 |
| 105 | positive regulation of interleukin-8 secretion (GO:2000484) | 3.49016460 |
| 106 | regulation of histone H3-K27 methylation (GO:0061085) | 3.48802161 |
| 107 | positive regulation of T cell mediated immunity (GO:0002711) | 3.48373532 |
| 108 | negative regulation of viral process (GO:0048525) | 3.46855923 |
| 109 | positive regulation of humoral immune response (GO:0002922) | 3.45306106 |
| 110 | regulation of T cell mediated cytotoxicity (GO:0001914) | 3.44763531 |
| 111 | negative regulation of T cell receptor signaling pathway (GO:0050860) | 3.43724737 |
| 112 | heterotypic cell-cell adhesion (GO:0034113) | 3.39980430 |
| 113 | pyrimidine ribonucleoside metabolic process (GO:0046131) | 3.38960205 |
| 114 | positive regulation of leukocyte mediated immunity (GO:0002705) | 3.37208820 |
| 115 | T cell activation (GO:0042110) | 3.36911737 |
| 116 | regulation of lymphocyte migration (GO:2000401) | 3.35997100 |
| 117 | T cell activation involved in immune response (GO:0002286) | 3.35971163 |
| 118 | regulation of defense response to virus by host (GO:0050691) | 3.35032812 |
| 119 | T cell proliferation (GO:0042098) | 3.34716431 |
| 120 | regulation of viral genome replication (GO:0045069) | 3.31594059 |
| 121 | regulation of immunoglobulin production (GO:0002637) | 3.31333741 |
| 122 | modulation of transcription in other organism involved in symbiotic interaction (GO:0052312) | 3.31169848 |
| 123 | positive regulation of T cell chemotaxis (GO:0010820) | 3.30352079 |
| 124 | regulation of T cell chemotaxis (GO:0010819) | 3.30352079 |
| 125 | negative regulation of type 2 immune response (GO:0002829) | 3.26039197 |
| 126 | regulation of leukocyte mediated immunity (GO:0002703) | 3.21663469 |
| 127 | positive regulation of tolerance induction (GO:0002645) | 3.20268026 |
| 128 | pyrimidine-containing compound catabolic process (GO:0072529) | 3.19098692 |
| 129 | positive regulation of macrophage differentiation (GO:0045651) | 3.16479734 |
| 130 | antigen processing and presentation of endogenous antigen (GO:0019883) | 3.16197586 |
| 131 | regulation of type I interferon-mediated signaling pathway (GO:0060338) | 3.15973535 |
| 132 | negative regulation of adaptive immune response (GO:0002820) | 3.15332597 |
| 133 | Arp2/3 complex-mediated actin nucleation (GO:0034314) | 3.14290115 |
| 134 | positive regulation of lamellipodium assembly (GO:0010592) | 3.12353583 |
| 135 | positive regulation of adaptive immune response based on somatic recombination of immune receptors b | 3.11093719 |
| 136 | mast cell activation (GO:0045576) | 3.09015633 |
| 137 | granulocyte activation (GO:0036230) | 3.06266103 |
| 138 | positive regulation of T-helper 1 type immune response (GO:0002827) | 2.96906407 |
| 139 | positive regulation of CD4-positive, alpha-beta T cell activation (GO:2000516) | 2.95783686 |
| 140 | regulation of T cell mediated immunity (GO:0002709) | 2.94822173 |
| 141 | regulation of T-helper 1 type immune response (GO:0002825) | 2.94405733 |
| 142 | DNA dealkylation (GO:0035510) | 2.91139899 |
| 143 | negative regulation of lymphocyte apoptotic process (GO:0070229) | 2.91010340 |
| 144 | negative regulation of alpha-beta T cell activation (GO:0046636) | 2.90756742 |
| 145 | positive regulation of activated T cell proliferation (GO:0042104) | 2.90552170 |
| 146 | leukocyte degranulation (GO:0043299) | 2.88384518 |
| 147 | negative regulation of adaptive immune response based on somatic recombination of immune receptors b | 2.88316541 |
| 148 | negative regulation of leukocyte mediated immunity (GO:0002704) | 2.88261510 |
| 149 | cytidine metabolic process (GO:0046087) | 13.1493662 |
| 150 | cytidine catabolic process (GO:0006216) | 13.1493662 |
| 151 | cytidine deamination (GO:0009972) | 13.1493662 |
| 152 | pyrimidine ribonucleoside catabolic process (GO:0046133) | 11.8946169 |
| 153 | interferon-gamma production (GO:0032609) | 10.6222677 |
| 154 | regulation of single stranded viral RNA replication via double stranded DNA intermediate (GO:0045091 | 10.2636847 |
| 155 | DNA deamination (GO:0045006) | 10.0256958 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 8.02315924 |
| 2 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 7.24339980 |
| 3 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 4.86107638 |
| 4 | RUNX_20019798_ChIP-Seq_JUKART_Human | 4.32551035 |
| 5 | * STAT4_19710469_ChIP-ChIP_TH1__Mouse | 4.25122278 |
| 6 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 4.04561111 |
| 7 | FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 3.96094141 |
| 8 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 3.76917458 |
| 9 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 3.65800680 |
| 10 | MYB_26560356_Chip-Seq_TH2_Human | 3.59722295 |
| 11 | MAF_26560356_Chip-Seq_TH1_Human | 3.20614765 |
| 12 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 3.17338578 |
| 13 | MYB_26560356_Chip-Seq_TH1_Human | 3.10275744 |
| 14 | CIITA_18437201_ChIP-ChIP_Raji_B_and_iDC_Human | 3.09928016 |
| 15 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 2.83119649 |
| 16 | UTX_26944678_Chip-Seq_JUKART_Human | 2.79768179 |
| 17 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 2.76693321 |
| 18 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 2.73215305 |
| 19 | GLI1_17442700_ChIP-ChIP_MESCs_Mouse | 2.60288936 |
| 20 | MYC_22102868_ChIP-Seq_BL_Human | 2.52371900 |
| 21 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 2.47444921 |
| 22 | NOTCH1_21737748_ChIP-Seq_TLL_Human | 2.30122106 |
| 23 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 2.16759242 |
| 24 | GATA3_27048872_Chip-Seq_THYMUS_Human | 2.15303545 |
| 25 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 2.11113314 |
| 26 | E2F7_22180533_ChIP-Seq_HELA_Human | 2.10362171 |
| 27 | SPI1_23547873_ChIP-Seq_NB4_Human | 2.03061387 |
| 28 | ELF1_17652178_ChIP-ChIP_JURKAT_Human | 1.98469222 |
| 29 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 1.98062491 |
| 30 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.96706535 |
| 31 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 1.94042962 |
| 32 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.92434217 |
| 33 | SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 1.92126214 |
| 34 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 1.91504628 |
| 35 | FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.89635424 |
| 36 | VDR_22108803_ChIP-Seq_LS180_Human | 1.88045387 |
| 37 | MAF_26560356_Chip-Seq_TH2_Human | 1.85112671 |
| 38 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 1.79890256 |
| 39 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 1.76823177 |
| 40 | RUNX1_17652178_ChIP-ChIP_JURKAT_Human | 1.74484704 |
| 41 | KDM2B_26808549_Chip-Seq_HPB-ALL_Human | 1.70332085 |
| 42 | HOXA2_22223247_ChIP-Seq_E11.5_EMBRYO_Mouse | 1.68294087 |
| 43 | SCL_19346495_ChIP-Seq_HPC-7_Human | 1.58959387 |
| 44 | TCF7_22412390_ChIP-Seq_EML_Mouse | 1.56454638 |
| 45 | VDR_21846776_ChIP-Seq_THP-1_Human | 1.51791641 |
| 46 | KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 1.46609001 |
| 47 | VDR_24763502_ChIP-Seq_THP-1_Human | 1.43722838 |
| 48 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 1.43521796 |
| 49 | FLI1_27457419_Chip-Seq_LIVER_Mouse | 1.43421800 |
| 50 | CTNNB1_24651522_ChIP-Seq_LGR5+_INTESTINAL_STEM_Human | 1.38240784 |
| 51 | E4F1_26484288_ChIP-Seq_MOUSE_EMBRYONIC_FIBROBLAST_Mouse | 1.38090844 |
| 52 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 1.37018024 |
| 53 | SPI1_23127762_ChIP-Seq_K562_Human | 1.34693541 |
| 54 | GATA3_26560356_Chip-Seq_TH2_Human | 1.34245645 |
| 55 | GABP_17652178_ChIP-ChIP_JURKAT_Human | 1.32366679 |
| 56 | PU_27001747_Chip-Seq_BMDM_Mouse | 1.29623669 |
| 57 | TAL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.27345836 |
| 58 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 1.25596909 |
| 59 | GATA2_22383799_ChIP-Seq_G1ME_Mouse | 1.25525021 |
| 60 | IRF1_19129219_ChIP-ChIP_H3396_Human | 1.25154845 |
| 61 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.21075670 |
| 62 | KDM2B_26808549_Chip-Seq_DND41_Human | 1.18770667 |
| 63 | ASXL1_24218140_ChIP-Seq_BMDM_Mouse | 1.17744581 |
| 64 | PCGF2_27294783_Chip-Seq_ESCs_Mouse | 1.13681588 |
| 65 | CEBPB_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.13619443 |
| 66 | * HTT_18923047_ChIP-ChIP_STHdh_Human | 1.13149305 |
| 67 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 1.11612143 |
| 68 | CEBPB_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.09941933 |
| 69 | GFI1B_20887958_ChIP-Seq_HPC-7_Mouse | 1.08386512 |
| 70 | * PAX6_23342162_ChIP-ChIP_BETA-FORBRAIN-LENS_Mouse | 1.08230444 |
| 71 | CEBPA_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.06248510 |
| 72 | PBX1_22567123_ChIP-ChIP_OVCAR3_Human | 1.05163340 |
| 73 | LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 1.04645834 |
| 74 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 1.04029792 |
| 75 | SFPI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.03839015 |
| 76 | TAL1_22897851_ChIP-Seq_JUKARTE6-1_Human | 1.03058751 |
| 77 | TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 1.01009521 |
| 78 | GATA3_26560356_Chip-Seq_TH1_Human | 1.00218506 |
| 79 | * HOXB4_20404135_ChIP-ChIP_EML_Mouse | 0.98981958 |
| 80 | VDR_24787735_ChIP-Seq_THP-1_Human | 0.98782202 |
| 81 | KDM2B_26808549_Chip-Seq_JURKAT_Human | 0.98133441 |
| 82 | GATA3_22897851_ChIP-Seq_JUKARTE6-1_Human | 0.97503102 |
| 83 | ERG_20887958_ChIP-Seq_HPC-7_Mouse | 0.96513576 |
| 84 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 0.96311083 |
| 85 | VDR_23849224_ChIP-Seq_CD4+_Human | 0.95201417 |
| 86 | * FOXA1_21572438_ChIP-Seq_LNCaP_Human | 0.93863384 |
| 87 | PU.1_20513432_ChIP-Seq_Bcells_Mouse | 0.92652735 |
| 88 | EGR1_19032775_ChIP-ChIP_M12_Human | 0.92580425 |
| 89 | GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 0.91950472 |
| 90 | CEBPB_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.90309488 |
| 91 | FOXH1_21741376_ChIP-Seq_EPCs_Human | 0.89458286 |
| 92 | BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 0.85776458 |
| 93 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 0.84422170 |
| 94 | BCL6_27268052_Chip-Seq_Bcells_Human | 0.84124943 |
| 95 | PRDM14_20953172_ChIP-Seq_ESCs_Human | 0.83728605 |
| 96 | PCGF2_27294783_Chip-Seq_NPCs_Mouse | 0.83284122 |
| 97 | SPI1_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 0.82930261 |
| 98 | RUNX1_22897851_ChIP-Seq_JUKARTE6-1_Human | 0.82528011 |
| 99 | PPARG_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 0.79728560 |
| 100 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 0.79068763 |
| 101 | NFE2_27457419_Chip-Seq_LIVER_Mouse | 0.78850180 |
| 102 | PPARG_20176806_ChIP-Seq_MACROPHAGES_Mouse | 0.78517372 |
| 103 | * FOXA1_27270436_Chip-Seq_PROSTATE_Human | 0.78106373 |
| 104 | * FOXA1_25329375_ChIP-Seq_VCAP_Human | 0.78106373 |
| 105 | SUZ12_27294783_Chip-Seq_NPCs_Mouse | 0.78076537 |
| 106 | TAF2_19829295_ChIP-Seq_ESCs_Human | 0.77696279 |
| 107 | FOXP3_21729870_ChIP-Seq_TREG_Human | 0.77001008 |
| 108 | NOTCH1_17114293_ChIP-ChIP_T-ALL_Human | 0.76897278 |
| 109 | POU3F2_20337985_ChIP-ChIP_501MEL_Human | 0.76768624 |
| 110 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 0.76100273 |
| 111 | SRF_21415370_ChIP-Seq_HL-1_Mouse | 0.75944456 |
| 112 | JARID1A_20064375_ChIP-Seq_MESCs_Mouse | 0.75330593 |
| 113 | NCOR1_26117541_ChIP-Seq_K562_Human | 0.74472213 |
| 114 | SOX9_22984422_ChIP-ChIP_TESTIS_Rat | 0.74470365 |
| 115 | PU.1_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.72990109 |
| 116 | NANOG_20526341_ChIP-Seq_ESCs_Human | 0.72785891 |
| 117 | P300_27268052_Chip-Seq_Bcells_Human | 0.72022042 |
| 118 | TP53_22573176_ChIP-Seq_HFKS_Human | 0.71446203 |
| 119 | GATA3_21878914_ChIP-Seq_MCF-7_Human | 0.71387172 |
| 120 | E2F4_17652178_ChIP-ChIP_JURKAT_Human | 0.70532231 |
| 121 | EZH2_27294783_Chip-Seq_NPCs_Mouse | 0.69834969 |
| 122 | FLI1_21867929_ChIP-Seq_CD8_Mouse | 0.69831274 |
| 123 | RUNX1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.69215690 |
| 124 | EST1_17652178_ChIP-ChIP_JURKAT_Human | 0.69113995 |
| 125 | MYC_19829295_ChIP-Seq_ESCs_Human | 0.69078239 |
| 126 | GATA6_21074721_ChIP-Seq_CACO-2_Mouse | 0.68002809 |
| 127 | SPI1_20517297_ChIP-Seq_HL60_Human | 0.67878167 |
| 128 | VDR_20736230_ChIP-Seq_LYMPHOBLASTOID_Human | 0.67380565 |
| 129 | TAL1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 0.67363357 |
| 130 | GBX2_23144817_ChIP-Seq_PC3_Human | 0.66247262 |
| 131 | GATA2_19941826_ChIP-Seq_K562_Human | 0.65535336 |
| 132 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 0.64256286 |
| 133 | GATA1_22383799_ChIP-Seq_G1ME_Mouse | 0.63812030 |
| 134 | GATA6_21074721_ChIP-Seq_CACO-2_Human | 0.63407869 |
| 135 | * EBNA2_21746931_ChIP-Seq_IB4-LCL_Human | 0.62982457 |
| 136 | PU.1_20176806_ChIP-Seq_MACROPHAGES_Mouse | 0.62845577 |
| 137 | HOXC9_25013753_ChIP-Seq_NEUROBLASTOMA_BE2-C_Human | 0.62637602 |
| 138 | AR_20517297_ChIP-Seq_VCAP_Human | 0.62292369 |
| 139 | EWS-ERG_20517297_ChIP-Seq_CADO-ES1_Human | 0.61923364 |
| 140 | TDRD3_21172665_ChIP-Seq_MCF-7_Human | 0.61488433 |
| 141 | FLI1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.61407735 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0005671_abnormal_response_to | 6.65911773 |
| 2 | MP0003763_abnormal_thymus_physiology | 5.18058081 |
| 3 | MP0006082_CNS_inflammation | 4.89639160 |
| 4 | MP0009785_altered_susceptibility_to | 4.00463647 |
| 5 | MP0001800_abnormal_humoral_immune | 3.29621228 |
| 6 | MP0000569_abnormal_digit_pigmentation | 3.09668779 |
| 7 | MP0002420_abnormal_adaptive_immunity | 3.09278277 |
| 8 | MP0001819_abnormal_immune_cell | 3.04928037 |
| 9 | MP0001835_abnormal_antigen_presentation | 3.02426978 |
| 10 | MP0005025_abnormal_response_to | 3.00762767 |
| 11 | MP0005000_abnormal_immune_tolerance | 2.97433708 |
| 12 | MP0002723_abnormal_immune_serum | 2.93486810 |
| 13 | MP0009333_abnormal_splenocyte_physiolog | 2.89625221 |
| 14 | MP0001790_abnormal_immune_system | 2.79767162 |
| 15 | MP0005387_immune_system_phenotype | 2.79767162 |
| 16 | MP0000685_abnormal_immune_system | 2.79548558 |
| 17 | MP0000858_altered_metastatic_potential | 2.74845516 |
| 18 | MP0002398_abnormal_bone_marrow | 2.72183702 |
| 19 | MP0002166_altered_tumor_susceptibility | 2.66932525 |
| 20 | MP0003448_altered_tumor_morphology | 2.63330894 |
| 21 | MP0002006_tumorigenesis | 2.60525352 |
| 22 | MP0002452_abnormal_antigen_presenting | 2.59927699 |
| 23 | MP0000716_abnormal_immune_system | 2.41219988 |
| 24 | MP0002405_respiratory_system_inflammati | 2.39879007 |
| 25 | MP0000703_abnormal_thymus_morphology | 2.33359867 |
| 26 | MP0001873_stomach_inflammation | 2.30304327 |
| 27 | MP0003724_increased_susceptibility_to | 2.27547105 |
| 28 | MP0002722_abnormal_immune_system | 2.17040029 |
| 29 | MP0002009_preneoplasia | 2.16123010 |
| 30 | MP0003436_decreased_susceptibility_to | 2.12701623 |
| 31 | MP0002148_abnormal_hypersensitivity_rea | 2.05028298 |
| 32 | MP0000689_abnormal_spleen_morphology | 2.04962328 |
| 33 | MP0003866_abnormal_defecation | 1.96540330 |
| 34 | MP0003183_abnormal_peptide_metabolism | 1.94790972 |
| 35 | MP0002429_abnormal_blood_cell | 1.91540640 |
| 36 | MP0010155_abnormal_intestine_physiology | 1.86910909 |
| 37 | MP0002419_abnormal_innate_immunity | 1.84980743 |
| 38 | MP0004947_skin_inflammation | 1.84803373 |
| 39 | MP0004381_abnormal_hair_follicle | 1.77872832 |
| 40 | MP0003786_premature_aging | 1.70163081 |
| 41 | MP0001845_abnormal_inflammatory_respons | 1.68376443 |
| 42 | MP0002163_abnormal_gland_morphology | 1.65694530 |
| 43 | MP0002132_abnormal_respiratory_system | 1.64334733 |
| 44 | MP0002933_joint_inflammation | 1.56989309 |
| 45 | MP0005464_abnormal_platelet_physiology | 1.48916342 |
| 46 | MP0002837_dystrophic_cardiac_calcinosis | 1.42022097 |
| 47 | MP0008469_abnormal_protein_level | 1.35713522 |
| 48 | MP0002396_abnormal_hematopoietic_system | 1.34177852 |
| 49 | MP0003045_fibrosis | 1.32396516 |
| 50 | MP0004510_myositis | 1.32025648 |
| 51 | MP0002877_abnormal_melanocyte_morpholog | 1.30175647 |
| 52 | MP0001851_eye_inflammation | 1.29730276 |
| 53 | MP0002277_abnormal_respiratory_mucosa | 1.25327791 |
| 54 | MP0002019_abnormal_tumor_incidence | 1.25185421 |
| 55 | MP0000490_abnormal_crypts_of | 1.17711878 |
| 56 | MP0005310_abnormal_salivary_gland | 1.16291109 |
| 57 | MP0002736_abnormal_nociception_after | 1.15015998 |
| 58 | MP0003300_gastrointestinal_ulcer | 1.14719826 |
| 59 | MP0002876_abnormal_thyroid_physiology | 1.11123634 |
| 60 | MP0008877_abnormal_DNA_methylation | 1.10449568 |
| 61 | MP0009763_increased_sensitivity_to | 1.01579211 |
| 62 | MP0002998_abnormal_bone_remodeling | 1.01457386 |
| 63 | MP0010307_abnormal_tumor_latency | 0.97871482 |
| 64 | MP0008007_abnormal_cellular_replicative | 0.94647211 |
| 65 | MP0001533_abnormal_skeleton_physiology | 0.94144703 |
| 66 | MP0005167_abnormal_blood-brain_barrier | 0.91944553 |
| 67 | MP0003950_abnormal_plasma_membrane | 0.91747015 |
| 68 | MP0001968_abnormal_touch/_nociception | 0.88263677 |
| 69 | MP0005075_abnormal_melanosome_morpholog | 0.87409614 |
| 70 | MP0004742_abnormal_vestibular_system | 0.87026612 |
| 71 | MP0005165_increased_susceptibility_to | 0.86825121 |
| 72 | MP0005166_decreased_susceptibility_to | 0.83971163 |
| 73 | MP0005377_hearing/vestibular/ear_phenot | 0.79972628 |
| 74 | MP0003878_abnormal_ear_physiology | 0.79972628 |
| 75 | MP0005408_hypopigmentation | 0.78074067 |
| 76 | MP0005451_abnormal_body_composition | 0.76442147 |
| 77 | MP0001853_heart_inflammation | 0.76373361 |
| 78 | MP0001502_abnormal_circadian_rhythm | 0.75991812 |
| 79 | MP0001986_abnormal_taste_sensitivity | 0.75221146 |
| 80 | MP0000465_gastrointestinal_hemorrhage | 0.74929880 |
| 81 | MP0000920_abnormal_myelination | 0.74884311 |
| 82 | MP0000015_abnormal_ear_pigmentation | 0.73339328 |
| 83 | MP0003959_abnormal_lean_body | 0.72717501 |
| 84 | MP0005379_endocrine/exocrine_gland_phen | 0.72449875 |
| 85 | MP0005253_abnormal_eye_physiology | 0.72374179 |
| 86 | MP0009764_decreased_sensitivity_to | 0.72308114 |
| 87 | MP0001919_abnormal_reproductive_system | 0.71480296 |
| 88 | MP0003453_abnormal_keratinocyte_physiol | 0.71470236 |
| 89 | MP0003075_altered_response_to | 0.71055625 |
| 90 | MP0005174_abnormal_tail_pigmentation | 0.69751597 |
| 91 | MP0000613_abnormal_salivary_gland | 0.68900728 |
| 92 | MP0006072_abnormal_retinal_apoptosis | 0.68196344 |
| 93 | MP0000343_altered_response_to | 0.66589266 |
| 94 | MP0002095_abnormal_skin_pigmentation | 0.66276932 |
| 95 | MP0004142_abnormal_muscle_tone | 0.66092890 |
| 96 | MP0005410_abnormal_fertilization | 0.64338633 |
| 97 | MP0003880_abnormal_central_pattern | 0.63412496 |
| 98 | MP0001765_abnormal_ion_homeostasis | 0.62850719 |
| 99 | MP0002138_abnormal_hepatobiliary_system | 0.62761574 |
| 100 | MP0009765_abnormal_xenobiotic_induced | 0.61163203 |
| 101 | MP0004808_abnormal_hematopoietic_stem | 0.59242009 |
| 102 | MP0002653_abnormal_ependyma_morphology | 0.58966039 |
| 103 | MP0005636_abnormal_mineral_homeostasis | 0.58955665 |
| 104 | MP0002136_abnormal_kidney_physiology | 0.58751837 |
| 105 | MP0000372_irregular_coat_pigmentation | 0.57127279 |
| 106 | MP0005023_abnormal_wound_healing | 0.55280128 |
| 107 | MP0002693_abnormal_pancreas_physiology | 0.55050754 |
| 108 | MP0003303_peritoneal_inflammation | 0.54102356 |
| 109 | MP0001243_abnormal_dermal_layer | 0.53786026 |
| 110 | MP0000427_abnormal_hair_cycle | 0.52489969 |
| 111 | MP0008873_increased_physiological_sensi | 0.51421948 |
| 112 | MP0001188_hyperpigmentation | 0.50410716 |
| 113 | MP0008058_abnormal_DNA_repair | 0.49738403 |
| 114 | MP0001501_abnormal_sleep_pattern | 0.49247516 |
| 115 | MP0005076_abnormal_cell_differentiation | 0.47798660 |
| 116 | MP0002168_other_aberrant_phenotype | 0.47123413 |
| 117 | MP0003943_abnormal_hepatobiliary_system | 0.46243558 |
| 118 | MP0001905_abnormal_dopamine_level | 0.45564938 |
| 119 | MP0000609_abnormal_liver_physiology | 0.44732084 |
| 120 | MP0009379_abnormal_foot_pigmentation | 0.42961536 |
| 121 | MP0001663_abnormal_digestive_system | 0.42489973 |
| 122 | MP0000477_abnormal_intestine_morphology | 0.42292199 |
| 123 | MP0003172_abnormal_lysosome_physiology | 0.42195483 |
| 124 | MP0008569_lethality_at_weaning | 0.39302419 |
| 125 | MP0002083_premature_death | 0.39167220 |
| 126 | MP0001191_abnormal_skin_condition | 0.39117152 |
| 127 | MP0009643_abnormal_urine_homeostasis | 0.38541514 |
| 128 | MP0004957_abnormal_blastocyst_morpholog | 0.37758004 |
| 129 | MP0006054_spinal_hemorrhage | 0.34546949 |
| 130 | MP0006292_abnormal_olfactory_placode | 0.34248707 |
| 131 | MP0005584_abnormal_enzyme/coenzyme_acti | 0.33736074 |
| 132 | MP0003795_abnormal_bone_structure | 0.33516862 |
| 133 | MP0000249_abnormal_blood_vessel | 0.31796712 |
| 134 | MP0000367_abnormal_coat/_hair | 0.31486463 |
| 135 | MP0000371_diluted_coat_color | 0.31112066 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | T lymphocytopenia (HP:0005403) | 7.87540074 |
| 2 | Abnormality of T cell number (HP:0011839) | 7.53858653 |
| 3 | Severe combined immunodeficiency (HP:0004430) | 5.80624413 |
| 4 | Aplastic anemia (HP:0001915) | 5.44436023 |
| 5 | Combined immunodeficiency (HP:0005387) | 5.34350988 |
| 6 | Retrobulbar optic neuritis (HP:0100654) | 5.29872743 |
| 7 | Optic neuritis (HP:0100653) | 5.29872743 |
| 8 | Myositis (HP:0100614) | 5.23375286 |
| 9 | Abnormality of T cells (HP:0002843) | 5.07903906 |
| 10 | Encephalitis (HP:0002383) | 4.95604468 |
| 11 | Orchitis (HP:0100796) | 4.56841610 |
| 12 | Nasal polyposis (HP:0100582) | 4.39307599 |
| 13 | Meningitis (HP:0001287) | 4.23120126 |
| 14 | Elevated erythrocyte sedimentation rate (HP:0003565) | 4.20823945 |
| 15 | Gastrointestinal infarctions (HP:0005244) | 4.17157590 |
| 16 | Joint swelling (HP:0001386) | 4.13467910 |
| 17 | IgG deficiency (HP:0004315) | 4.05474519 |
| 18 | Increased IgM level (HP:0003496) | 4.00890444 |
| 19 | Thyroiditis (HP:0100646) | 3.96252064 |
| 20 | Stomatitis (HP:0010280) | 3.93651936 |
| 21 | Hypoproteinemia (HP:0003075) | 3.91964856 |
| 22 | Keratoconjunctivitis sicca (HP:0001097) | 3.75119673 |
| 23 | Recurrent fungal infections (HP:0002841) | 3.75058566 |
| 24 | Eczematoid dermatitis (HP:0000976) | 3.72608475 |
| 25 | Abnormality of eosinophils (HP:0001879) | 3.68685158 |
| 26 | Hemoptysis (HP:0002105) | 3.65783453 |
| 27 | Recurrent bronchitis (HP:0002837) | 3.58195579 |
| 28 | Abnormality of the nasal mucosa (HP:0000433) | 3.50206937 |
| 29 | IgM deficiency (HP:0002850) | 3.49513690 |
| 30 | Recurrent cutaneous fungal infections (HP:0011370) | 3.45291936 |
| 31 | Chronic mucocutaneous candidiasis (HP:0002728) | 3.45291936 |
| 32 | Hemiplegia (HP:0002301) | 3.44156200 |
| 33 | Pulmonary infiltrates (HP:0002113) | 3.41393698 |
| 34 | Obstructive lung disease (HP:0006536) | 3.41187137 |
| 35 | Chronic obstructive pulmonary disease (HP:0006510) | 3.41187137 |
| 36 | Keratoconjunctivitis (HP:0001096) | 3.38593388 |
| 37 | Carpal bone hypoplasia (HP:0001498) | 3.38455370 |
| 38 | Vasculitis (HP:0002633) | 3.31913400 |
| 39 | Autoimmune hemolytic anemia (HP:0001890) | 3.27079566 |
| 40 | Leukocytosis (HP:0001974) | 3.25988613 |
| 41 | Chronic diarrhea (HP:0002028) | 3.20358006 |
| 42 | Arterial thrombosis (HP:0004420) | 3.16952253 |
| 43 | Recurrent abscess formation (HP:0002722) | 3.10454436 |
| 44 | Panhypogammaglobulinemia (HP:0003139) | 3.10103000 |
| 45 | Gangrene (HP:0100758) | 3.09533523 |
| 46 | Pulmonary embolism (HP:0002204) | 3.09144465 |
| 47 | Recurrent viral infections (HP:0004429) | 2.99350045 |
| 48 | Hyponatremia (HP:0002902) | 2.98497509 |
| 49 | Cutaneous melanoma (HP:0012056) | 2.95546681 |
| 50 | Mediastinal lymphadenopathy (HP:0100721) | 2.91060426 |
| 51 | Abnormality of binocular vision (HP:0011514) | 2.80291134 |
| 52 | Diplopia (HP:0000651) | 2.80291134 |
| 53 | Abnormal delayed hypersensitivity skin test (HP:0002963) | 2.78492925 |
| 54 | Pustule (HP:0200039) | 2.78370855 |
| 55 | Eosinophilia (HP:0001880) | 2.78243800 |
| 56 | Abnormality of the prostate (HP:0008775) | 2.76274357 |
| 57 | Abnormality of T cell physiology (HP:0011840) | 2.76092058 |
| 58 | Menstrual irregularities (HP:0000858) | 2.75072113 |
| 59 | Anorexia (HP:0002039) | 2.71006445 |
| 60 | Abnormality of macrophages (HP:0004311) | 2.70455719 |
| 61 | Ureteral stenosis (HP:0000071) | 2.68527800 |
| 62 | Lymphopenia (HP:0001888) | 2.66728825 |
| 63 | Spontaneous hematomas (HP:0007420) | 2.66563099 |
| 64 | Lymphoma (HP:0002665) | 2.59395706 |
| 65 | Abnormality of cells of the lymphoid lineage (HP:0012140) | 2.54623469 |
| 66 | IgA deficiency (HP:0002720) | 2.54066581 |
| 67 | Inflammation of the large intestine (HP:0002037) | 2.51658115 |
| 68 | Hypergammaglobulinemia (HP:0010702) | 2.50374664 |
| 69 | Aplasia/Hypoplasia involving the carpal bones (HP:0006502) | 2.47216327 |
| 70 | Abnormality of the fingertips (HP:0001211) | 2.46781881 |
| 71 | Hypoplasia of the thymus (HP:0000778) | 2.45861081 |
| 72 | Gastrointestinal inflammation (HP:0004386) | 2.45207388 |
| 73 | Increased IgE level (HP:0003212) | 2.41799837 |
| 74 | Ureteral obstruction (HP:0006000) | 2.38712471 |
| 75 | Recurrent sinusitis (HP:0011108) | 2.35920568 |
| 76 | Chest pain (HP:0100749) | 2.33863966 |
| 77 | Epistaxis (HP:0000421) | 2.32417051 |
| 78 | Glomerulopathy (HP:0100820) | 2.30927640 |
| 79 | Agammaglobulinemia (HP:0004432) | 2.30881797 |
| 80 | Abnormality of sodium homeostasis (HP:0010931) | 2.30665200 |
| 81 | Purpura (HP:0000979) | 2.25636597 |
| 82 | Hypoalbuminemia (HP:0003073) | 2.22952604 |
| 83 | Abnormal albumin level (HP:0012116) | 2.22952604 |
| 84 | Recurrent skin infections (HP:0001581) | 2.22612636 |
| 85 | Granulocytopenia (HP:0001913) | 2.21533862 |
| 86 | Abnormality of oral frenula (HP:0000190) | 2.19913989 |
| 87 | Keratitis (HP:0000491) | 2.16660503 |
| 88 | Increased serum ferritin (HP:0003281) | 2.16521056 |
| 89 | Aortic dissection (HP:0002647) | 2.15758856 |
| 90 | Gingivitis (HP:0000230) | 2.13787959 |
| 91 | Amaurosis fugax (HP:0100576) | 2.12698246 |
| 92 | Abnormality of liposaccharide metabolism (HP:0010968) | 2.12270770 |
| 93 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 2.12270770 |
| 94 | Abnormality of glycolipid metabolism (HP:0010969) | 2.12270770 |
| 95 | Abnormality of the pleura (HP:0002103) | 2.12172142 |
| 96 | Hepatosplenomegaly (HP:0001433) | 2.11354796 |
| 97 | Polyneuropathy (HP:0001271) | 2.09288346 |
| 98 | Abnormality of the common coagulation pathway (HP:0010990) | 2.06126784 |
| 99 | Pigmentary retinal degeneration (HP:0001146) | 2.03846119 |
| 100 | Chronic otitis media (HP:0000389) | 2.01068741 |
| 101 | Acrocyanosis (HP:0001063) | 2.00371993 |
| 102 | Autoimmune thrombocytopenia (HP:0001973) | 1.99789145 |
| 103 | Frequent falls (HP:0002359) | 1.98933957 |
| 104 | Prolonged neonatal jaundice (HP:0006579) | 1.98442722 |
| 105 | J-shaped sella turcica (HP:0002680) | 1.94727877 |
| 106 | Tetraplegia (HP:0002445) | 1.92556970 |
| 107 | Cheilitis (HP:0100825) | 1.90430602 |
| 108 | Microcytic anemia (HP:0001935) | 1.90424532 |
| 109 | Bronchitis (HP:0012387) | 1.89330904 |
| 110 | Decreased circulating renin level (HP:0003351) | 1.88511910 |
| 111 | Abnormality of the pericardium (HP:0001697) | 1.88346574 |
| 112 | Petechiae (HP:0000967) | 1.86624476 |
| 113 | Renal cortical cysts (HP:0000803) | 1.86367365 |
| 114 | Periodontitis (HP:0000704) | 1.85239892 |
| 115 | Increased CSF protein (HP:0002922) | 1.83087102 |
| 116 | Acute hepatic failure (HP:0006554) | 1.82210655 |
| 117 | Pancytopenia (HP:0001876) | 1.81490994 |
| 118 | Alveolar cell carcinoma (HP:0006519) | 1.79844882 |
| 119 | Abnormality of the endocardium (HP:0004306) | 1.79048044 |
| 120 | Basal ganglia calcification (HP:0002135) | 1.78046940 |
| 121 | Porencephaly (HP:0002132) | 1.76992698 |
| 122 | 3-Methylglutaconic aciduria (HP:0003535) | 1.75009565 |
| 123 | Congenital stationary night blindness (HP:0007642) | 1.74725954 |
| 124 | Recurrent bacterial skin infections (HP:0005406) | 1.73632684 |
| 125 | Congenital nonbullous ichthyosiform erythroderma (HP:0007479) | 1.71210823 |
| 126 | Pulmonary fibrosis (HP:0002206) | 1.71109926 |
| 127 | Increased neuronal autofluorescent lipopigment (HP:0002074) | 1.70728268 |
| 128 | Arthralgia (HP:0002829) | 1.69249552 |
| 129 | Acne (HP:0001061) | 1.67768043 |
| 130 | Parkinsonism with favorable response to dopaminergic medication (HP:0002548) | 1.66575857 |
| 131 | Skin rash (HP:0000988) | 1.65010976 |
| 132 | Neuroendocrine neoplasm (HP:0100634) | 1.64853799 |
| 133 | Glucose intolerance (HP:0000833) | 1.64853677 |
| 134 | Retinopathy (HP:0000488) | 1.63819791 |
| 135 | Squamous cell carcinoma (HP:0002860) | 1.61649663 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | TXK | 7.45315443 |
| 2 | ITK | 4.03900047 |
| 3 | MAP4K1 | 3.91237721 |
| 4 | JAK1 | 2.88109889 |
| 5 | JAK3 | 2.77853731 |
| 6 | TSSK6 | 2.53348720 |
| 7 | TESK2 | 2.45235648 |
| 8 | ZAP70 | 2.44880088 |
| 9 | PIK3CA | 2.35126606 |
| 10 | MST4 | 2.32801958 |
| 11 | STK38 | 2.26994887 |
| 12 | STK10 | 2.24328902 |
| 13 | PRKD2 | 2.23832354 |
| 14 | CSK | 2.17757875 |
| 15 | GRK6 | 2.12739787 |
| 16 | NLK | 2.07496168 |
| 17 | CLK1 | 1.98154451 |
| 18 | LCK | 1.93630780 |
| 19 | IKBKE | 1.93500155 |
| 20 | GRK7 | 1.91742721 |
| 21 | IRAK4 | 1.84027994 |
| 22 | FGFR4 | 1.79703644 |
| 23 | EIF2AK3 | 1.62169886 |
| 24 | KDR | 1.59847406 |
| 25 | MAP3K14 | 1.53609116 |
| 26 | TEC | 1.52403954 |
| 27 | TBK1 | 1.50921750 |
| 28 | TYK2 | 1.48451114 |
| 29 | MAP3K12 | 1.43996917 |
| 30 | BTK | 1.43676808 |
| 31 | FGFR3 | 1.35690839 |
| 32 | MAPKAPK3 | 1.33098851 |
| 33 | TLK1 | 1.22929463 |
| 34 | WNK4 | 1.22803978 |
| 35 | PRKCQ | 1.22085665 |
| 36 | TNK2 | 1.21866946 |
| 37 | ACVR1B | 1.19773663 |
| 38 | NUAK1 | 1.18041755 |
| 39 | BLK | 1.15404285 |
| 40 | HCK | 1.12303173 |
| 41 | FES | 1.07036228 |
| 42 | MAP2K7 | 1.05522243 |
| 43 | PIM1 | 1.05425009 |
| 44 | TGFBR2 | 1.04759363 |
| 45 | MAP3K11 | 1.00503233 |
| 46 | EPHB1 | 0.99628126 |
| 47 | MAP2K6 | 0.98700071 |
| 48 | SYK | 0.96894577 |
| 49 | DMPK | 0.96808237 |
| 50 | SRPK1 | 0.94410070 |
| 51 | IRAK1 | 0.94109281 |
| 52 | IRAK3 | 0.93367834 |
| 53 | NEK9 | 0.92033865 |
| 54 | STK11 | 0.91467447 |
| 55 | MAP3K3 | 0.87809763 |
| 56 | HIPK2 | 0.86165830 |
| 57 | SIK3 | 0.84653364 |
| 58 | LYN | 0.84286226 |
| 59 | TAOK3 | 0.83816381 |
| 60 | MAPK11 | 0.82986849 |
| 61 | ADRBK2 | 0.79541086 |
| 62 | EPHA3 | 0.77253624 |
| 63 | PRKCH | 0.75425281 |
| 64 | BCR | 0.73092745 |
| 65 | IRAK2 | 0.71959499 |
| 66 | RET | 0.71943047 |
| 67 | MAPKAPK2 | 0.71046370 |
| 68 | CAMKK2 | 0.69867751 |
| 69 | MAP3K1 | 0.66756730 |
| 70 | RAF1 | 0.64572645 |
| 71 | SIK2 | 0.62388311 |
| 72 | CSF1R | 0.62169959 |
| 73 | FRK | 0.59431238 |
| 74 | TESK1 | 0.56182316 |
| 75 | RPS6KA4 | 0.55568392 |
| 76 | RPS6KA5 | 0.54349902 |
| 77 | JAK2 | 0.54041616 |
| 78 | IGF1R | 0.52621022 |
| 79 | CDK9 | 0.51838378 |
| 80 | MAP3K10 | 0.51538066 |
| 81 | IKBKB | 0.48121721 |
| 82 | FYN | 0.47520222 |
| 83 | MAP2K3 | 0.47330332 |
| 84 | CDK4 | 0.47287592 |
| 85 | PTK2B | 0.46630502 |
| 86 | MARK3 | 0.46630131 |
| 87 | INSR | 0.45421701 |
| 88 | LRRK2 | 0.42213300 |
| 89 | STK24 | 0.42055311 |
| 90 | FER | 0.41955583 |
| 91 | DAPK2 | 0.40990784 |
| 92 | TYRO3 | 0.40961665 |
| 93 | MELK | 0.40758165 |
| 94 | LIMK1 | 0.39344638 |
| 95 | NEK6 | 0.39222728 |
| 96 | BCKDK | 0.38669403 |
| 97 | FGR | 0.37741878 |
| 98 | NME2 | 0.37600352 |
| 99 | TTN | 0.35812341 |
| 100 | FGFR1 | 0.35212702 |
| 101 | EIF2AK1 | 0.35121235 |
| 102 | CSNK1G1 | 0.35058437 |
| 103 | VRK2 | 0.34331644 |
| 104 | DAPK1 | 0.33637004 |
| 105 | SGK3 | 0.33463862 |
| 106 | GRK5 | 0.31801330 |
| 107 | MAP3K13 | 0.30938655 |
| 108 | ALK | 0.29250471 |
| 109 | ATR | 0.29052827 |
| 110 | STK39 | 0.28296235 |
| 111 | KIT | 0.27676679 |
| 112 | YES1 | 0.27284541 |
| 113 | ABL1 | 0.24926038 |
| 114 | PRKCD | 0.24250264 |
| 115 | CSNK1G3 | 0.23150905 |
| 116 | MAPK15 | 0.22938745 |
| 117 | PDK1 | 0.22782171 |
| 118 | BUB1 | 0.22118363 |
| 119 | ERN1 | 0.22052315 |
| 120 | CAMK2A | 0.22051636 |
| 121 | CAMK2D | 0.21277918 |
| 122 | CSNK1A1L | 0.20387957 |
| 123 | PRKG2 | 0.19933481 |
| 124 | PRKD1 | 0.19846370 |
| 125 | SGK2 | 0.19582203 |
| 126 | PIK3CG | 0.19517443 |
| 127 | MYLK | 0.19320266 |
| 128 | PRKCE | 0.18453603 |
| 129 | MAP3K7 | 0.18124797 |
| 130 | BMPR2 | 0.17713466 |
| 131 | OXSR1 | 0.17409565 |
| 132 | MAPK12 | 0.16332055 |
| 133 | CDK6 | 0.16185370 |
| 134 | PDGFRB | 0.15276320 |
| 135 | EIF2AK2 | 0.14078631 |
| 136 | CHUK | 0.12732914 |
| 137 | CSNK1A1 | 0.12438393 |
| 138 | CSNK1G2 | 0.12210537 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Graft-versus-host disease_Homo sapiens_hsa05332 | 8.17318799 |
| 2 | * Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 4.68289349 |
| 3 | Allograft rejection_Homo sapiens_hsa05330 | 4.38973240 |
| 4 | Primary immunodeficiency_Homo sapiens_hsa05340 | 4.07766038 |
| 5 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 3.23315165 |
| 6 | * Antigen processing and presentation_Homo sapiens_hsa04612 | 3.21796665 |
| 7 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 3.10095764 |
| 8 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 2.85478720 |
| 9 | Viral myocarditis_Homo sapiens_hsa05416 | 2.72377676 |
| 10 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 2.62119471 |
| 11 | Proteasome_Homo sapiens_hsa03050 | 2.56828109 |
| 12 | Measles_Homo sapiens_hsa05162 | 2.40374809 |
| 13 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 2.28311186 |
| 14 | Leishmaniasis_Homo sapiens_hsa05140 | 1.56677506 |
| 15 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 1.54081712 |
| 16 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 1.44938162 |
| 17 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 1.44866387 |
| 18 | Malaria_Homo sapiens_hsa05144 | 1.38157041 |
| 19 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 1.36108407 |
| 20 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 1.29637011 |
| 21 | Osteoclast differentiation_Homo sapiens_hsa04380 | 1.29045254 |
| 22 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 1.20397786 |
| 23 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 1.20151484 |
| 24 | Glycosylphosphatidylinositol(GPI)-anchor biosynthesis_Homo sapiens_hsa00563 | 1.19247754 |
| 25 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 1.18822715 |
| 26 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 1.12315895 |
| 27 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 1.02952813 |
| 28 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 1.01925081 |
| 29 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 1.01882659 |
| 30 | Toxoplasmosis_Homo sapiens_hsa05145 | 1.00481738 |
| 31 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 0.97431468 |
| 32 | Protein export_Homo sapiens_hsa03060 | 0.95864660 |
| 33 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 0.95511315 |
| 34 | Herpes simplex infection_Homo sapiens_hsa05168 | 0.93645673 |
| 35 | Nitrogen metabolism_Homo sapiens_hsa00910 | 0.92251872 |
| 36 | Apoptosis_Homo sapiens_hsa04210 | 0.92179344 |
| 37 | Colorectal cancer_Homo sapiens_hsa05210 | 0.86144731 |
| 38 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 0.85218775 |
| 39 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 0.83600151 |
| 40 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 0.82938445 |
| 41 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 0.78037455 |
| 42 | Hepatitis B_Homo sapiens_hsa05161 | 0.77305170 |
| 43 | Shigellosis_Homo sapiens_hsa05131 | 0.75636182 |
| 44 | Ribosome_Homo sapiens_hsa03010 | 0.75543211 |
| 45 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 0.74391321 |
| 46 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 0.72916217 |
| 47 | Pancreatic cancer_Homo sapiens_hsa05212 | 0.71464786 |
| 48 | Influenza A_Homo sapiens_hsa05164 | 0.71236654 |
| 49 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.71083715 |
| 50 | HTLV-I infection_Homo sapiens_hsa05166 | 0.70039141 |
| 51 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.66261544 |
| 52 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 0.66247989 |
| 53 | TNF signaling pathway_Homo sapiens_hsa04668 | 0.65456268 |
| 54 | RNA polymerase_Homo sapiens_hsa03020 | 0.65121356 |
| 55 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 0.64016259 |
| 56 | Platelet activation_Homo sapiens_hsa04611 | 0.61155037 |
| 57 | Legionellosis_Homo sapiens_hsa05134 | 0.60992916 |
| 58 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 0.58765701 |
| 59 | Regulation of actin cytoskeleton_Homo sapiens_hsa04810 | 0.57352442 |
| 60 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 0.56625410 |
| 61 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 0.56567601 |
| 62 | Adherens junction_Homo sapiens_hsa04520 | 0.54630184 |
| 63 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 0.54520844 |
| 64 | Fatty acid elongation_Homo sapiens_hsa00062 | 0.54135572 |
| 65 | Endocytosis_Homo sapiens_hsa04144 | 0.50118913 |
| 66 | Parkinsons disease_Homo sapiens_hsa05012 | 0.49853013 |
| 67 | Galactose metabolism_Homo sapiens_hsa00052 | 0.48098866 |
| 68 | Thyroid cancer_Homo sapiens_hsa05216 | 0.47659223 |
| 69 | Salmonella infection_Homo sapiens_hsa05132 | 0.46642433 |
| 70 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 0.46380608 |
| 71 | Basal transcription factors_Homo sapiens_hsa03022 | 0.45910258 |
| 72 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 0.45464287 |
| 73 | Neuroactive ligand-receptor interaction_Homo sapiens_hsa04080 | 0.45069111 |
| 74 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 0.44337916 |
| 75 | Tuberculosis_Homo sapiens_hsa05152 | 0.44138344 |
| 76 | Hepatitis C_Homo sapiens_hsa05160 | 0.43287606 |
| 77 | Pertussis_Homo sapiens_hsa05133 | 0.42428777 |
| 78 | p53 signaling pathway_Homo sapiens_hsa04115 | 0.42125804 |
| 79 | Transcriptional misregulation in cancer_Homo sapiens_hsa05202 | 0.41607714 |
| 80 | Homologous recombination_Homo sapiens_hsa03440 | 0.41065867 |
| 81 | Spliceosome_Homo sapiens_hsa03040 | 0.39863250 |
| 82 | African trypanosomiasis_Homo sapiens_hsa05143 | 0.38813110 |
| 83 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 0.34637160 |
| 84 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.31288988 |
| 85 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 0.30636455 |
| 86 | Small cell lung cancer_Homo sapiens_hsa05222 | 0.28994556 |
| 87 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 0.27853477 |
| 88 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.27620209 |
| 89 | Viral carcinogenesis_Homo sapiens_hsa05203 | 0.27218742 |
| 90 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.27092067 |
| 91 | Other glycan degradation_Homo sapiens_hsa00511 | 0.25735533 |
| 92 | Olfactory transduction_Homo sapiens_hsa04740 | 0.25640992 |
| 93 | Alzheimers disease_Homo sapiens_hsa05010 | 0.25076626 |
| 94 | DNA replication_Homo sapiens_hsa03030 | 0.24600351 |
| 95 | Focal adhesion_Homo sapiens_hsa04510 | 0.24243283 |
| 96 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 0.22840649 |
| 97 | Circadian rhythm_Homo sapiens_hsa04710 | 0.22791375 |
| 98 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 0.22575999 |
| 99 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 0.22439387 |
| 100 | Endometrial cancer_Homo sapiens_hsa05213 | 0.22054586 |
| 101 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 0.21627647 |
| 102 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 0.21306800 |
| 103 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.21292643 |
| 104 | Rap1 signaling pathway_Homo sapiens_hsa04015 | 0.20725752 |
| 105 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 0.20101420 |
| 106 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.20094907 |
| 107 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.19930847 |
| 108 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.19895950 |
| 109 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 0.19424878 |
| 110 | Phototransduction_Homo sapiens_hsa04744 | 0.19391163 |
| 111 | Asthma_Homo sapiens_hsa05310 | 0.19098940 |
| 112 | RNA degradation_Homo sapiens_hsa03018 | 0.19069967 |
| 113 | FoxO signaling pathway_Homo sapiens_hsa04068 | 0.16437501 |
| 114 | Morphine addiction_Homo sapiens_hsa05032 | 0.15749299 |
| 115 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.15377487 |
| 116 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.15005102 |
| 117 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.15002823 |
| 118 | Fanconi anemia pathway_Homo sapiens_hsa03460 | 0.14363579 |
| 119 | Regulation of autophagy_Homo sapiens_hsa04140 | 0.12786440 |
| 120 | Prion diseases_Homo sapiens_hsa05020 | 0.12649468 |
| 121 | Prostate cancer_Homo sapiens_hsa05215 | 0.12329320 |
| 122 | Butanoate metabolism_Homo sapiens_hsa00650 | 0.11396983 |
| 123 | Renin-angiotensin system_Homo sapiens_hsa04614 | 0.10748628 |
| 124 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.10559451 |
| 125 | Lysosome_Homo sapiens_hsa04142 | 0.10295905 |
| 126 | Nucleotide excision repair_Homo sapiens_hsa03420 | 0.07812467 |
| 127 | Longevity regulating pathway - multiple species_Homo sapiens_hsa04213 | 0.07442584 |
| 128 | N-Glycan biosynthesis_Homo sapiens_hsa00510 | 0.07076002 |
| 129 | Pathways in cancer_Homo sapiens_hsa05200 | 0.07060191 |
| 130 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.06087681 |
| 131 | GABAergic synapse_Homo sapiens_hsa04727 | 0.05685042 |
| 132 | Pyrimidine metabolism_Homo sapiens_hsa00240 | 0.05094193 |
| 133 | Arrhythmogenic right ventricular cardiomyopathy (ARVC)_Homo sapiens_hsa05412 | 0.04701097 |
| 134 | Base excision repair_Homo sapiens_hsa03410 | 0.04540366 |
| 135 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.04466010 |
| 136 | Ether lipid metabolism_Homo sapiens_hsa00565 | 0.04287702 |
| 137 | Mineral absorption_Homo sapiens_hsa04978 | 0.03957057 |
| 138 | Caffeine metabolism_Homo sapiens_hsa00232 | 0.03853528 |
| 139 | mRNA surveillance pathway_Homo sapiens_hsa03015 | 0.02646731 |
| 140 | Amoebiasis_Homo sapiens_hsa05146 | 0.01415249 |
| 141 | Mismatch repair_Homo sapiens_hsa03430 | -0.0239332 |

